Insider Shareholders with Direct Ownership of Candel Therapeutics, Inc. (CADL)
This section provides a comprehensive overview of the insiders with direct ownership of Candel Therapeutics, Inc. (CADL). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Candel Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Estuardo Aguilar Cordova
Director |
297,320 | 54,074 | 1,097,032 $6.8 Million | 3 |
May 06, 2022
Reduced 4.7%
|
|
Laura K. Aguilar
> 10% Shareholder |
227,431 | 68,534 | 1,033,840 $6.41 Million | 3 |
May 06, 2022
Reduced 6.22%
|
|
Paul Peter Tak
Chief Executive Officer |
416,999 | 43,443 | 373,556 $2.32 Million | 6 |
Nov 28, 2023
Reduced 10.42%
|
|
Jason Amello
Chief Financial Officer |
222,162 | 20,153 | 202,009 $1.25 Million | 5 |
Nov 28, 2023
Reduced 9.07%
|
|
Francesca Barone
Chief Scientific Officer |
204,905 | 19,748 | 186,657 $1.16 Million | 4 |
Nov 28, 2023
Reduced 9.57%
|
|
Seshu Tyagarajan
Chief Technology Officer |
191,558 | 17,328 | 174,230 $1.08 Million | 5 |
Nov 28, 2023
Reduced 9.05%
|
| 27,000 | 0 | 152,000 $942,400 | 2 |
Dec 09, 2022
Added 13.61%
|
|
|
William Garrett Nichols
Chief Medical Officer |
147,301 | 12,175 | 135,126 $837,781 | 3 |
Nov 28, 2023
Reduced 8.27%
|
| 56,000 | 0 | 56,000 $347,200 | 2 |
Jul 29, 2021
Added 26.32%
|
|
| 38,032 | 0 | 38,032 $235,798 | 2 |
Dec 09, 2022
Added 47.94%
|
|
|
John J Canepa
Chief Financial Officer |
10,125 | 0 | 10,125 $62,775 | 1 |
Jul 29, 2021
Added 50.0%
|
| 10,000 | 0 | 10,000 $62,000 | 1 |
Jul 29, 2021
Added 50.0%
|
|
|
Nathan Caffo
Chief Business Officer |
6,000 | 0 | 6,000 $37,200 | 1 |
Jul 29, 2021
Added 50.0%
|